A theme to sell titin assay systems as research reagents and expand their applications to the diagnosis of muscular dystrophy, disease-state monitoring, and exercise monitoring. It also includes changing the sales format from certified testing reagents to research reagents and a weakening of the policy of seeking approval as a drug.